Suchergebnisse - "Schoindre, Yoland"

PubPharm (59)

1

Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia : A Secondary Analysis of a Randomized Clinical Trial

enthalten in: JAMA network open | 2021

von Dinh, A. | Duran, C. | Ropers, J. | +130

2

The ID NOW COVID-19, a high-speed high-performance assay

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2021

von Farfour, E. | Asso-Bonnet, M. | Vasse, M. | +40

3

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC) : a double-blind, randomised, placebo-controlled, non-inferiority trial

enthalten in: Lancet (London, England) | 2021

von Dinh, A. | Ropers, J. | Duran, C. | +129

CommentIn: Lancet. 2021 Mar 27;397(10280):1160-1161. - PMID 33773623

4

Tocilizumab for Severe Worsening COVID-19 Pneumonia : a Propensity Score Analysis

enthalten in: Journal of clinical immunology | 2021

von Roumier, M. | Paule, R. | Vallée, A. | +26

5

Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis : A classic skin rash with a necrotizing myositis and high risk of malignancy

enthalten in: Journal of the American Academy of Dermatology | 2020

von Monseau, G. | Landon-Cardinal, O. | Stenzel, W. | +45

CommentIn: J Am Acad Dermatol. 2020 Dec;83(6):e461-e462. - PMID 32758631

6

Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus : a case-control study with hydroxychloroquine blood-level analysis

enthalten in: Rheumatology (Oxford, England) | 2020

von Lenfant, T. | Salah, S. | Leroux, G. | +117

7

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial

enthalten in: bioRxiv.org | 2020

von Mahévas, M. | Tran, V. | Roumier, M. | +27

8

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis

enthalten in: Journal of clinical immunology | 2020

von Roumier, M. | Paule, R. | Vallée, A. | +25

9

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis

enthalten in: Journal of clinical immunology | 2020

von Roumier, M. | Paule, R. | Vallée, A. | +25

10

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis

enthalten in: Journal of clinical immunology | 2020

von Roumier, M. | Paule, R. | Vallée, A. | +25

1
2
3
4
5
6
Nächster »
[6]